Comorbidities of advanced diseases in patients with cystic fibrosis

J. Altenburg (Amsterdam (NH), Netherlands)

Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age
Session: Cystic fibrosis: from cradle to old age
Session type: Symposium
Number: 4423

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Altenburg (Amsterdam (NH), Netherlands). Comorbidities of advanced diseases in patients with cystic fibrosis. Virtual Congress 2020 – Cystic fibrosis: from cradle to old age

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease
Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020
Year: 2021



Comorbidities in cystic fibrosis
Source: International Congress 2015 – Comorbidities in COPD and other chronic lung diseases
Year: 2015



Factors affecting progression of lung disease among patients with cystic fibrosis
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019


Relations between the sinonasal development and the lung disease in cystic fibrosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 103s
Year: 2005

Risk factors for lung disease progression in children with cystic fibrosis
Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017
Year: 2018



Risk factors for lung disease progression in children with cystic fibrosis
Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018
Year: 2018



Early determinants of lung disease in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




Screening for cystic fibrosis among high risk group patients with chronic lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 340s
Year: 2002

Cystic fibrosis and arthritis in children
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


Pulmonary arterial hypertension and advanced lung disease in cystic fibrosis patients
Source: Eur Respir J 2007; 30: Suppl. 51, 387s
Year: 2007

Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015


Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Non invasive ventilation for advanced cystic fibrosis lung disease in children
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011


Pathophysiology of cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 1-13
Year: 2014


Comorbidities in interstitial lung diseases
Source: Eur Respir Rev 2017; 26: 160027
Year: 2017



Early cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 77-87
Year: 2014


Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 528s
Year: 2002

Non-pulmonary comorbidities in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015